Fig. 2
From: Divergent disruptive effects of soluble recombinant tau assemblies on synaptic plasticity in vivo

The TNFα inhibitor etanercept abrogates disruption of hippocampal LTP caused by oTau but not SτAs. (a, b) Co-injection of etanercept (Etn, 50 µg, i.c.v.) prevented the inhibition of LTP by i.c.v. injection of synaptotoxic oTau (12.3 pmol). Open triangle: injection of Vehicle, oTau or Etanercept + oTau. (c, d) Injection of etanercept (Etn, 50 µg, i.c.v.) did not prevent the inhibition of LTP caused by i.c.v. injection of SτAs (1.2 pmol, n = 4 pre-injected and n = 2 co-injected). Open triangle: injection of either Vehicle, SτAs or Etn co-injected with SτAs. Open triangle in parentheses: in a subset of experiments Etn was pre-injected 15 min before SτAs. Values are mean ± SEM. #p < 0.05, ##p < 0.01 compared with pre-HFS baseline, paired t-test; **p < 0.01, ***p < 0.001 one-way ANOVA followed by Bonferroni’s multiple-comparison tests